Application of customized industry-specific metrics to assessment of capital projects performances

KSCE Journal of Civil Engineering

Volumn 16, Issue 1, 2012, Pages 19-27

  Hwang, Bon Gang ^a   Thomas, Stephen R ^b   Caldas, Carlos H ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b The University of Texas at Austin   (United States)

Author keywords

benchmarking; construction management; performance evaluation; pharmaceutical project

Indexed keywords

CAPITAL PROJECTS; CONSTRUCTION MANAGEMENT; CONSTRUCTION PROJECTS; DELIVERY PROCESS; HIERARCHICAL STRUCTURES; METRIC VALUES; PERFORMANCE ASSESSMENT; PERFORMANCE EVALUATION; PHARMACEUTICAL INDUSTRY; PHARMACEUTICAL PROJECT; PROJECT COST;

BENCHMARKING; CONSTRUCTION INDUSTRY; COST BENEFIT ANALYSIS; MANUFACTURE; RATING;

PROJECT MANAGEMENT;

EID: 84855289034     PISSN: 12267988     EISSN: 19763808     Source Type: Journal    
DOI: 10.1007/s12205-012-1352-8     Document Type: Article

References (18)

1. Albright, S. C., Winston, W., and Zappe, C. J. (2003). Data analysis and decision making (2nd ed.), Thomson Learning, Inc., Pacific Grove, CA.
2. Bender, R. H. (1996). "Benchmark costs for pharmaceutical facilities." Pharmaceutical Engineering, Vol. 16, No. 6, pp. 28-34.
3. Dysert, L. (2001). "Sharpen your capital cost estimation skills." Chemical Engineering, Vol. 108, No. 11, pp. 70-81.
4. ECI (2008). About ECI, available at www. eci-online. org/pages/aboutus. html (accessed 29 December 2008).
5. Hwang, B. G., Thomas, S., Caldas, C., and Degezelle, D. (2008). "Development of a benchmarking framework for pharmaceutical capital projects." Construction Management and Economics, Vol. 26, No. 2, pp. 177-195.
6. Hwang, B. G., Thomas, S., and Caldas, C. (2010). "Performance metric development for pharmaceutical construction projects." International Journal of Project Management, Vol. 28, No. 3, pp. 265-274.
7. IPA (2008). About IPA, available at http://www. ipaglobal. com/inside%20pages/About_IPA/index. html (accessed 29 December 2008).
8. ISPE (International Society of Pharmaceutical Engineers) (1996). Pharmaceutical engineering guide for oral solid dosage forms, Vol. 2 (November), ISPE.
9. ISPE (1997). Pharmaceutical engineering guide for bulk pharmaceutical chemical facilities - Executive summary, Vol. 1 (November), ISPE.
10. ISPE (2003). Pharmaceutical engineering guide for biopharmaceuticals, Vol. 6 (January), ISPE.
11. ISPE (2008). Glossary of applied terminology for the pharmaceutical industry, ISPE, available at www. ispe. org/glossary (accessed 29 September 2008).
12. Kennedy, T. (1998). Pharmaceutical project management, Marcel Dekker Inc., NY.
13. Maleyeff, J. (2003). "Benchmarking performance indices: Pitfalls and solutions." Benchmarking: An International Journal, Vol. 10, No. 1, pp. 9-28.
14. Osborne, P. D. (1996). "Investment cost benchmarks for pharmaceutical facilities." Pharmaceutical Engineering, Vol. 16, No. 6, pp. 36-48.
15. Sakamoto, A. (2004). Linear model & structural equation system, SOC 385L (Spring), The University of Texas at Austin, Austin, TX.
16. Statsoft (2006). Basic statistics. Statsoft, Inc, available at http://www. statsoft. com/textbook/basic-statistics (accessed: 4 January 2009).
17. Thomas, S. R. (2003). Quantitative methods for project analysis, CE395R6 (Spring), The University of Texas at Austin, Austin, TX.
18. Wrigley, G. C. (2004). Facility validation: Theory, practice, and tools, CRC Press LLC, Boca Rayton, FL.